REGENERON PHARMACEUTICALS, INC. Logo

REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):
US75886F1075
LEI:
Country:
United States of America
Address:
777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea
145020
Humacyte, Inc. Logo
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America
HUMA
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation
ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea
205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea
200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea
243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea
084110
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea
061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium
HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.